Acute leukemiais characterized by the accumulation of malignantmyeloblastsorlymphoblastsin the bone marrow, blood, and/or other tissues. Thesurvival rateof acute myeloid leukemia (AML) patients less than 60 years is only 35–40%, while that of patients over 60 years is only 5–15%. The event...
C.: Long survivals in acute leukemia. Lancet i:534-538, 1973.Till MM,et al.Long survival in acute leukemia. The Lancet . 1973Long survival in acute leukemia. Till MM,et al. The Lancet . 1973TILL, M. M., HARDISTY, R. M. and PIKE, M. C. - Long survivals in acute leukemia. ...
Leukemia is a blood cancer that doesn't form solid tumors in your body. So, imaging tests such as X-rays, CT scans, MRIs, and ultrasounds won't help your doctor diagnose the cancer. But they can help your doctor figure out if you're having other problems, such as swelling in your ...
Infection with the human T-cell lymphoma/leukemia virus-1 (HTLV-1) or the Epstein-Barr virus (EBV), mostly outside the U.S. Having a medical condition that’s tied to your genes, such asDown syndrome Being white Being male Acute Lymphoblastic Leukemia Symptoms ...
Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhi
Acute myeloid leukemia (AML) is a highly malignant cancer of myeloid blood cells affecting about one million people globally in 20151,2. It most frequently occurs in older adults and shows a relatively poor five-year survival rate of about 25%, which is worsening with increasing age of a pat...
The five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is evident from a study of 800 Dutch children. Within the study, modified treatment protocols for four subgroups were examined.
Blinatumomab Boosts Survival in MRD-Negative BCP-ALL Jared Kaltwasser Adding blinatumomab to consolidation chemotherapy for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in patients without measurable residual disease (MRD) led to improvements in overall and relapse-free survival. ...
Thus, high-dose chemo/radiotherapy followed by allogeneic marrow infusion has a curative potential for patients with refractory leukemia and offers the chance of long-term disease-free survival for some patients. 展开 关键词: Humans Leukemia Acute Disease Recurrence Disease-Free Survival Transplantation...
were well correlated (R(2)=0.88-0.93).The significant correlations between overall survival and the surrogate end point (leukemia-free survival) and between the effect of histamine dihydrochloride/interleukin-2 on leukemia-free survival and overall survival satisfy the two-stage surrogate validation ...